A method for comparing multiple imputation techniques: a case study on the U.S. National COVID Cohort Collaborative
Authors:
Elena Casiraghi,
Rachel Wong,
Margaret Hall,
Ben Coleman,
Marco Notaro,
Michael D. Evans,
Jena S. Tronieri,
Hannah Blau,
Bryan Laraway,
Tiffany J. Callahan,
Lauren E. Chan,
Carolyn T. Bramante,
John B. Buse,
Richard A. Moffitt,
Til Sturmer,
Steven G. Johnson,
Yu Raymond Shao,
Justin Reese,
Peter N. Robinson,
Alberto Paccanaro,
Giorgio Valentini,
Jared D. Huling,
Kenneth Wilkins,
:,
Tell Bennet
, et al. (12 additional authors not shown)
Abstract:
Healthcare datasets obtained from Electronic Health Records have proven to be extremely useful to assess associations between patients' predictors and outcomes of interest. However, these datasets often suffer from missing values in a high proportion of cases and the simple removal of these cases may introduce severe bias. For these reasons, several multiple imputation algorithms have been propose…
▽ More
Healthcare datasets obtained from Electronic Health Records have proven to be extremely useful to assess associations between patients' predictors and outcomes of interest. However, these datasets often suffer from missing values in a high proportion of cases and the simple removal of these cases may introduce severe bias. For these reasons, several multiple imputation algorithms have been proposed to attempt to recover the missing information. Each algorithm presents strengths and weaknesses, and there is currently no consensus on which multiple imputation algorithms works best in a given scenario. Furthermore, the selection of each algorithm parameters and data-related modelling choices are also both crucial and challenging. In this paper, we propose a novel framework to numerically evaluate strategies for handling missing data in the context of statistical analysis, with a particular focus on multiple imputation techniques. We demonstrate the feasibility of our approach on a large cohort of type-2 diabetes patients provided by the National COVID Cohort Collaborative (N3C) Enclave, where we explored the influence of various patient characteristics on outcomes related to COVID-19. Our analysis included classic multiple imputation techniques as well as simple complete-case Inverse Probability Weighted models. The experiments presented here show that our approach could effectively highlight the most valid and performant missing-data handling strategy for our case study. Moreover, our methodology allowed us to gain an understanding of the behavior of the different models and of how it changed as we modified their parameters. Our method is general and can be applied to different research fields and on datasets containing heterogeneous types.
△ Less
Submitted 25 September, 2022; v1 submitted 13 June, 2022;
originally announced June 2022.
Learning Interpretable Disease Self-Representations for Drug Repositioning
Authors:
Fabrizio Frasca,
Diego Galeano,
Guadalupe Gonzalez,
Ivan Laponogov,
Kirill Veselkov,
Alberto Paccanaro,
Michael M. Bronstein
Abstract:
Drug repositioning is an attractive cost-efficient strategy for the development of treatments for human diseases. Here, we propose an interpretable model that learns disease self-representations for drug repositioning. Our self-representation model represents each disease as a linear combination of a few other diseases. We enforce proximity in the learnt representations in a way to preserve the ge…
▽ More
Drug repositioning is an attractive cost-efficient strategy for the development of treatments for human diseases. Here, we propose an interpretable model that learns disease self-representations for drug repositioning. Our self-representation model represents each disease as a linear combination of a few other diseases. We enforce proximity in the learnt representations in a way to preserve the geometric structure of the human phenome network - a domain-specific knowledge that naturally adds relational inductive bias to the disease self-representations. We prove that our method is globally optimal and show results outperforming state-of-the-art drug repositioning approaches. We further show that the disease self-representations are biologically interpretable.
△ Less
Submitted 20 October, 2019; v1 submitted 14 September, 2019;
originally announced September 2019.
